Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
10/1997
10/23/1997WO1997039028A1 Mutant plasminogen activator-inhibitor type 1 (pai-1) and uses thereof
10/23/1997WO1997039024A1 Cyclic prodrugs of peptides and peptide nucleic acids having improved metabolic stability and cell membrane permeability
10/23/1997WO1997039023A1 Cysteine-containing or methioine-containing peptides with immunomodulatory effects
10/23/1997WO1997039022A1 Novel compounds
10/23/1997WO1997039021A1 Targeted therapeutic or diagnostic agents and methods of making and using same
10/23/1997WO1997039020A2 Antigenic sequences of a sperm protein and immunocontraceptive methods
10/23/1997WO1997039017A1 STREPTOCOCCUS PNEUMONIAE HISTIDYL tRNA SYNTHETASE
10/23/1997WO1997039016A1 NOVEL LysS PROTEINS FROM STREPTOCOCCUS PNEUMONIAE
10/23/1997WO1997039014A1 STREPTOCOCCUS PNEUMONIAE ASPARTYL tRNA SYNTHETASE
10/23/1997WO1997039013A1 STREPTOCOCCUS PNEUMONIAE ALANYL tRNA SYNTHETASE
10/23/1997WO1997039011A1 STREPTOCOCCUS PNEUMONIAE ISOLEUCYL tRNA SYNTHETASE
10/23/1997WO1997039009A1 Recombinant antigens useful for the serodiagnosis of neosporosis
10/23/1997WO1997038969A1 pH-SENSITIVE POLYMERS
10/23/1997WO1997038729A1 In vivo gene transfer methods for wound healing
10/23/1997WO1997038722A1 Novel compounds
10/23/1997WO1997038721A1 Novel compounds
10/23/1997WO1997038720A1 Novel compounds
10/23/1997WO1997038719A1 Novel compounds
10/23/1997WO1997038717A1 Novel compounds
10/23/1997WO1997038716A1 Novel compounds
10/23/1997WO1997038715A1 Novel compounds
10/23/1997WO1997038714A1 Novel compounds
10/23/1997WO1997038712A1 Intestinal trefoil proteins
10/23/1997WO1997038711A2 T-cell dependent vaccine and the cell surface receptor cd28
10/23/1997WO1997038710A1 Synthesis of human procollagens and collagens in recombinant dna systems
10/23/1997WO1997038704A1 Treatment of bone disorders with adrenomedullin
10/23/1997WO1997038703A1 Chimeric isoprenoid synthases and uses thereof
10/23/1997WO1997038571A1 Compositions and methods for taxol biosynthesis
10/23/1997WO1997035005A3 Cftr gene regulator
10/23/1997WO1997034996A3 Induction quiescence in bacterial cells and uses thereof
10/23/1997WO1997032019A3 C-c ckr-5, cc-chemikines receptor, derivatives thereof and their uses
10/23/1997WO1997031114A3 Polynucleotides and aminoacid sequences from staphylococcus aureus
10/23/1997WO1997031104A3 Candida albicans profilin gene
10/23/1997WO1997031019A3 Antipathogenic peptides and compositions comprising them
10/23/1997WO1997030158A3 Recombinant protein containing a c-terminal fragment of plasmodium msp-1
10/23/1997WO1997028187A3 Multivalent chimeric peptides as microbicides
10/23/1997WO1997026853A3 Dna encoding galanin galr2 receptors and uses thereof
10/23/1997WO1997025068A3 Mesothelin antigen and methods and kits for targeting it
10/23/1997WO1997024446A3 Gene delivery vehicle-targeting ligands
10/23/1997WO1997023631A3 Globins containing binding domains
10/23/1997WO1997021812A3 Mammalian chemokine ccf8 and chemokine receptor cckr3
10/23/1997WO1997014798A3 Polynucleotides and proteins coded thereby useful for controlling melolontha sp. cockchafers
10/23/1997WO1997014789A3 Enzymatic array and process of making same
10/23/1997WO1997012992A3 Diagnosis method for a disease caused by a frameshift mutation in a gene and reagents therefore
10/23/1997WO1996034890A3 Inhibitors of fibrin cross-linking and/or transglutaminases
10/23/1997DE19617846A1 Gene transfection process of human dendritic cells
10/23/1997DE19617837A1 Anticancer vaccine containing human dendritic cells
10/23/1997DE19615803A1 CELO-Virus CELO virus
10/23/1997DE19615710A1 Verfahren zur Gewinnung und Anwendung eines biologisch aktiven Eiweisstoffes - Kollagenfragment HF-COLL-18/514cf - in partiell aufgereinigter und synthetischer Form aus Körperflüssigkeiten zur Beeinflussung des Zellwachstums und der Diagnose von Kollagenerkrankungen sowie der Osteoporose Methods for obtaining and application of a biologically active Eiweisstoffes - collagen fragment HF-COLL-18 / 514cf - in partially purified form from body fluids and synthetic for influencing the cell growth and the diagnosis of collagen diseases and osteoporosis
10/23/1997CA2252228A1 Treatment of bone disorders with adrenomedullin
10/23/1997CA2252225A1 Use of a modified rev-responsive element (rre) in methods and compositions for combatting hiv infection
10/23/1997CA2252082A1 Hybrid interferon compositions and methods of use
10/23/1997CA2251904A1 An antigenic epitope of the a determinant of hepatitis b surface antigen and uses thereof
10/23/1997CA2251818A1 Mammalian genes involved in viral infection and tumor suppression
10/23/1997CA2251745A1 Non-a-non-e hepatitis virus having a translatable core region, reagents and methods for their use
10/23/1997CA2251670A1 Recombinant antigens useful for the serodiagnosis of neosporosis
10/23/1997CA2251631A1 Intestinal trefoil proteins
10/23/1997CA2251115A1 Novel rantes homolog from prostate
10/23/1997CA2250975A1 Soluble 7-transmembrane domain g-protein-coupled receptor compositions and methods
10/23/1997CA2250707A1 Cysteine-containing or methionine-containing peptides with immunomodulatory effects
10/23/1997CA2241051A1 Targeted therapeutic or diagnostic agents and methods of making and using same
10/23/1997CA2224859A1 Ligand inhibitors of insulin-like growth factor binding proteins and methods of use therefor
10/23/1997CA2224571A1 Cytoplasmic modulators of integrin regulation/signaling
10/23/1997CA2219151A1 Cyclic prodrugs of peptides and peptide nucleic acids having improved metabolic stability and cell membrane permeability
10/22/1997EP0801744A1 Peptide reagent for detecting a primary epstein-barr virus infection by testing for the corresponding antibodies, and method for using same
10/22/1997EP0801685A1 Methods for detecting mutations associated with hypertrophic cardiomyopathy
10/22/1997EP0801682A1 Process for the production of proteins
10/22/1997EP0801678A1 Recombinant swinepox virus
10/22/1997EP0801657A1 Retinoid x receptor-interacting polypeptides and related molecules and methods
10/22/1997EP0801656A1 Induction of cytotoxic t-lymphocyte responses
10/22/1997EP0801575A1 Retroviral vectors for expression in embryonic cells
10/22/1997EP0801574A1 Modulation of integrin-mediated signal transduction
10/22/1997EP0778890A4 Dna encoding a human calcium channel alpha-1e subunit
10/22/1997EP0693122A4 Glutamylcysteine synthetase light subunit
10/22/1997EP0576426B1 Ryegrass pollen allergen
10/22/1997EP0551449B1 Method for producing a subunit vaccine against porcine parvovirus
10/22/1997EP0491033B1 Isolation and purification of lung surfactant protein
10/22/1997EP0485458B1 Thioacylating reagents and intermediates, thiopeptides, and methods for preparing and using same
10/22/1997EP0228458B2 Epithelial cells expressing foreign genetic material
10/22/1997CN1162978A Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof
10/22/1997CN1162600A Mutant human growth hormones and their uses
10/21/1997US5679880 Oral immunization by transgenic plants
10/21/1997US5679784 Recombinant dna molecule comprising adenylate cyclase gene of bordetella
10/21/1997US5679783 Chordin polypeptide capable of inducing dorsal and neural tissue development in vertebrates; neurotropic growth factor
10/21/1997US5679777 Time-release agents comprising conjugates of genetically engineered proteins as drug carriers; enhanced stability; increased vascular retention
10/21/1997US5679776 Contacting plasma with barium chloride, collecting supernatant, contacting supernatant with aluminum hydroxide, centrifuging, desalting, ion exchanging, collecting factor viii complex
10/21/1997US5679775 Process and device for the simultaneous extracorporeal elimination of tumour necrosis factor and bacterial lipopolysaccharides from whole blood and/or blood plasma
10/21/1997US5679774 DNA sequences of the EBV genome, recombinant DNA molecules, processes for preparing EBV-related antigens, diagnostic compositions and pharmaceutical compositions containing said antigens
10/21/1997US5679772 Medical diagnosis, immunoassays
10/21/1997US5679771 Administering mammalian insulin-like growth factor
10/21/1997US5679770 Polypeptide, DNA fragment encoding the same, drug composition containing the same and process for producing the same
10/21/1997US5679768 Epitopic regions of pneumococcal surface protein A
10/21/1997US5679653 Diagnosis and treatment of bacterial dystentery
10/21/1997US5679647 Methods and devices for immunizing a host against tumor-associated antigens through administration of naked polynucleotides which encode tumor-associated antigenic peptides
10/21/1997US5679641 Peptides of human P53 protein for use in human T cell response inducing compositions, and human P53 protein-specific cytotoxic t-lymphocytes
10/21/1997US5679640 Immunosuppressant peptides
10/21/1997US5679639 Serine protease derived-polypeptides and anti-peptide antibodies, systems and therapeutic methods for inhibiting coagulation
10/21/1997US5679636 Bone and prostate-derived protein factors affecting prostate cancer growth, differentiation, and metastasis
10/21/1997US5679566 Yeast NMD2 gene
10/21/1997US5679560 Genes for the synthesis of antipathogenic substances